Singapore, Singapore

Peng Fei Jackson Koh

This inventor holds 1 USPTO granted patent. Top assignee: Nanyang Technological University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Fei Jackson Koh. Retrieved from https://idiyas.com/inventor/peng-fei-jackson-koh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Peng Fei Jackson Koh

Introduction

Peng Fei Jackson Koh is a notable inventor based in Singapore, recognized for his contributions to the field of neuropharmacology. He has developed innovative compounds that have potential therapeutic applications. His work is particularly focused on neurokinin-1 (NK1) receptor antagonists, which are significant in the treatment of various neurological conditions.

Latest Patents

Koh holds a patent for his invention titled "3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists." This patent involves the synthesis of 3-piperidone compounds, specifically (2S)-phenyl-3-piperidone, and outlines their use as potent NK1 receptor antagonists. The invention presents a novel approach to addressing neurological disorders through these compounds.

Career Highlights

Currently, Peng Fei Jackson Koh is affiliated with Nanyang Technological University, where he engages in research and development in the field of pharmacology. His academic background and research endeavors have positioned him as a key figure in his area of expertise.

Collaborations

Koh collaborates with esteemed colleagues, including Teck Peng Loh and Peng Wang, who contribute to his research initiatives. Their combined efforts enhance the scope and impact of their work in the scientific community.

Conclusion

Peng Fei Jackson Koh's innovative work in developing neurokinin-1 receptor antagonists showcases his commitment to advancing medical science. His contributions are paving the way for potential breakthroughs in treating neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…